articleCancer ResearchJun 19, 2012GREEN OA

Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · Johns Hopkins University · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Continued androgen receptor (AR) signaling is an established mechanism underlying castration-resistant prostate cancer (CRPC), and suppression of androgen receptor signaling remains a therapeutic goal of CRPC therapy. Constitutively active androgen receptor splice variants (AR-Vs) lack the androgen receptor ligand-binding domain (AR-LBD), the intended target of androgen deprivation therapies including CRPC therapies such as abiraterone and MDV3100. While the canonical full-length androgen receptor (AR-FL) and AR-Vs are both increased in CRPCs, their expression regulation, associated transcriptional programs, and functional relationships have not been dissected. In this study, we show that suppression of…

Citation impact

588
total citations
FWCI
42.58
Percentile
100%
References
20
Citations per year

Authors

12

Topics & keywords

Keywords
  • Prostate cancer
  • splice
  • Androgen receptor
  • Castration
  • Androgen
  • Medicine
  • Alternative splicing
  • Cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding